Therefore, in this study, we investigated whether exogenous supplementation with irisin would protect against diabetic cardiomyopathy and found that irisin supplementation attenuates cardiac injury in T1DM mice by an anti-ferroptosis action, via SIRT1-mediated deacetylation of p53. Here, TP53 is linked to diabetic cardiomyopathy.